OSAIC HOLDINGS, INC. - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q3 2023$2,619
+37.3%
120
+100.0%
0.00%
Q2 2023$1,907
+30.3%
600.0%0.00%
Q1 2023$1,463
-26.8%
60
-7.7%
0.00%
Q4 2022$2,0000.0%650.0%0.00%
Q3 2022$2,000
-77.8%
65
-79.6%
0.00%
Q2 2022$9,000
-10.0%
319
+13.9%
0.00%
Q1 2022$10,000
+900.0%
280
+803.2%
0.00%
Q4 2021$1,000310.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q3 2023
NameSharesValueWeighting ↓
BAIN CAPITAL INVESTORS LLC 60,632,356$1,965,701,00023.51%
Affinity Asset Advisors, LLC 225,000$7,295,0002.65%
Perceptive Advisors 10,173,454$329,822,0002.54%
Artal Group S.A. 1,500,000$48,630,0001.32%
Rock Springs Capital Management LP 1,648,435$53,442,0001.24%
RTW INVESTMENTS, LP 666,666$21,613,0000.32%
BOULDER HILL CAPITAL MANAGEMENT LP 8,900$289,0000.28%
EAM Investors, LLC 39,907$1,294,0000.21%
FEDERATED HERMES, INC. 3,113,333$100,934,0000.19%
Alkeon Capital Management 1,909,035$61,891,0000.12%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders